La cadena de opciones muestra datos clave de las opciones de acciones de Pacific Biosciences a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Pacific Biosciences..

Pacific Biosciences (NASDAQ:PACB) Bolsa, Cadena de Opciones

PACIFIC BIOSCIENCES OF CALIF

Pacific Biosciences

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Russia,Moscow,24.06.2021,Logo,Of,Financial,Investing,Fund,Ark,Invest

Equities

News

Markets

ETFs

ARKK

ARKW

ARKX

CRSP

KTOS

PACB

PLTR

SHOP

Ark Invest modificó su cartera vendiendo acciones de Palantir y comprando AMD y Shopify. ¿Qué estrategia hay detrás?

Ark Invest refuerza su apuesta por AMD mientras reduce exposición a Palantir

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences of California Inc

Press Releases

PacBio to Present at Upcoming Investor Conferences

Contracts

Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025

QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels

Health Care

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

General

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

Analyst Ratings

Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

Earnings

PacBio Announces Second Quarter 2025 Financial Results

QGEN

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Azenta

BioLife Solutions

Codexis

Cytek Biosciences

CryoPort

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Pacific Biosciences

Pacific Biosciences (PACB) Opciones

Pacific Biosciences (NASDAQ:PACB) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL